Study of the gut microbiota modulatory potential of two popular drinks in northern Nigeria
Not Applicable
Recruiting
- Conditions
- Digestive SystemNutritional, Metabolic, EndocrineOral Health
- Registration Number
- PACTR202401853406618
- Lead Sponsor
- AUDU HARUNA JIMOH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Age between 18 and 30 years, good general health, and a signed consent form.
Exclusion Criteria
Engaging in any of these during 2 weeks prior to the first sample collection; antibiotic use, intentional intake of probiotic or prebiotic products, presence of gastrointestinal disorders such as diarrhea, inflammatory bowel disease, or irritable bowel syndrome, pregnancy or breastfeeding, alcoholism and drug addiction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms do popular northern Nigerian drinks use to modulate gut microbiota in metabolic diseases?
How do prebiotic and probiotic components in these drinks compare to standard-of-care treatments for dysbiosis-related conditions?
Which specific gut microbiota biomarkers are associated with improved metabolic outcomes in this trial?
What are the potential adverse events of long-term gut microbiota modulation using these traditional beverages?
Are there synergistic effects when combining these drinks with existing metabolic disorder therapies like GLP-1 agonists?